AMAG Pharmaceuticals, Inc. (AMAG): Rumor News

AMAG – Report that company has received interest from private equity.


Key Facts Surrounding This News Item


  • AMAG had a POWR Rating of F (Strong Sell) coming into today.
  • AMAG was -5.70% below its 10-Day Moving Average coming into today.
  • AMAG was -7.38% below its 20-Day Moving Average coming into today.
  • AMAG was -8.22% below its 50-Day Moving Average coming into today.
  • AMAG was -14.45% below its 100-Day Moving Average coming into today.
  • AMAG was -23.38% below its 200-Day Moving Average coming into today.
  • AMAG had returned -2.26% year-to-date leading up to today’s news, versus a -2.01% return from the benchmark S&P 500 during the same period.

More Info About AMAG Pharmaceuticals, Inc. (AMAG)


AMAG Pharmaceuticals has a diverse portfolio of products in the areas of maternal health, anemia management and cancer supportive care. The company was founded in 1981 and is based in Waltham, Massachusetts. View our full AMAG ticker page with ratings, news, and more.

Try StockNews.com Premium Today!


Get access to our daily newsletters, Best Stocks List, POWR Ratings, and much more!
Free for 14 days -- no credit card required!

Sign Up Now

AMAG at a Glance

AMAG Current POWR Rating™
Overall POWR Rating™
AMAG Current Price $24.80 0.40%
More AMAG Ratings, Data, and News

AMAG Price Reaction

The day of this event (Feb. 12, 2018)
AMAG Closing Price$13.53 4.44%
AMAG Volume1,782,800
82.87% from avg
Leading up to this event
AMAG 1-mo return10.07%
After this event
AMAG 1-day return5.47%
AMAG 3-day return27.86%
AMAG 5-day return32.90%

AMAG Price Chart



More AMAG Pharmaceuticals, Inc. (AMAG) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All AMAG News
Page generated in 1.1528 seconds.